JPRN-jRCT2031210208CompletedPhase 1
A clinical trial of STN1013400 ophthalmic solution in healthy adult male volunteer for single and repeated dose - Phase I, clinical pharmacological trial
Migita Yukie0 sites48 target enrollmentStarted: July 26, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 48
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to <= 50age old (—)
- Sex
- Male
Inclusion Criteria
- •Subjects who can comply with scheduled visits and the examination and observation as specified in the clinical study protocol
Exclusion Criteria
- •1)Subjects have a disease and/or abnormal laboratory value which is considered inappropriate from safety evaluation perspective
- •2)Subjects who are inappropriate as participants in this study in the opinion of the investigator or sub investigator
Investigators
Similar Trials
Recruiting
Phase 1
A phase I/IIa study of STN1014100 ophthalmic solution in healthy adult male volunteers and dry eye patientsDry eyeJPRN-jRCT2051220152Koji Oka134
Completed
Phase 1
A phase I study of STN1013600 ophthalmic solution in healthy adult male volunteerPresbyopiaJPRN-jRCT2031210614Migita Yukie24
Completed
Phase 1
Pharmacokinetic study of STN1012600 ophthalmic solution in healthy adult males volunteersJPRN-jRCT2051230035Koji Oka8
Completed
Phase 2
Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With PresbyopiaPresbyopiaNCT05665387Santen Inc.79
Recruiting
Phase 3
A Study in Chinese Patients With Acquired BlepharoptosisBlepharoptosisNCT06683651Santen Pharmaceutical Co., Ltd.180